Stoke Therapeutics Stock Market Value
| STOK Stock | USD 11.91 0.14 1.19% |
| Symbol | Stoke |
Stoke Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.08) | Revenue Per Share 0.328 | Quarterly Revenue Growth 0.479 | Return On Assets (0.28) | Return On Equity (0.52) |
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Stoke Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Stoke Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Stoke Therapeutics.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Stoke Therapeutics on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Stoke Therapeutics or generate 0.0% return on investment in Stoke Therapeutics over 30 days. Stoke Therapeutics is related to or competes with Ikena Oncology, Eliem Therapeutics, HCW Biologics, RenovoRx, Tempest Therapeutics, Scpharmaceuticals, and Milestone Pharmaceuticals. Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide medicines t... More
Stoke Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Stoke Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Stoke Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 21.35 | |||
| Value At Risk | (6.99) | |||
| Potential Upside | 4.68 |
Stoke Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stoke Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Stoke Therapeutics' standard deviation. In reality, there are many statistical measures that can use Stoke Therapeutics historical prices to predict the future Stoke Therapeutics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.13) |
Stoke Therapeutics Backtested Returns
Stoke Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0681, which indicates the firm had a -0.0681% return per unit of risk over the last 3 months. Stoke Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Stoke Therapeutics' Coefficient Of Variation of (2,217), variance of 13.21, and Risk Adjusted Performance of (0.03) to confirm the risk estimate we provide. The entity has a beta of 1.32, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Stoke Therapeutics will likely underperform. At this point, Stoke Therapeutics has a negative expected return of -0.25%. Please make sure to validate Stoke Therapeutics' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Stoke Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.57 |
Good reverse predictability
Stoke Therapeutics has good reverse predictability. Overlapping area represents the amount of predictability between Stoke Therapeutics time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Stoke Therapeutics price movement. The serial correlation of -0.57 indicates that roughly 57.0% of current Stoke Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.57 | |
| Spearman Rank Test | -0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.74 |
Stoke Therapeutics lagged returns against current returns
Autocorrelation, which is Stoke Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Stoke Therapeutics' stock expected returns. We can calculate the autocorrelation of Stoke Therapeutics returns to help us make a trade decision. For example, suppose you find that Stoke Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Stoke Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Stoke Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Stoke Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Stoke Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Stoke Therapeutics Lagged Returns
When evaluating Stoke Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Stoke Therapeutics stock have on its future price. Stoke Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Stoke Therapeutics autocorrelation shows the relationship between Stoke Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Stoke Therapeutics.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Stoke Therapeutics Correlation, Stoke Therapeutics Volatility and Stoke Therapeutics Alpha and Beta module to complement your research on Stoke Therapeutics. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Stoke Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.